Decision-making - the Benefit of Bedside CRP Within Ambulance Care (Q-CRP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04097210|
Recruitment Status : Completed
First Posted : September 20, 2019
Last Update Posted : September 20, 2019
|Condition or disease||Intervention/treatment|
|Critical Illness||Diagnostic Test: POC|
Purpose: To improve identification and proper prioritization of patients with non-specific symptoms prehospitally, we intend to investigate whether Q-CRP, a rapid test for CRP, correlates with time-critical states in the above-mentioned patient group alone or together with CRP, lactate and suPAR. The primary endpoint is need for hospital care.
Material: Patients over 18 years who exhibit non-specific symptoms and transported to the emergency room.
Method: In patients with unspecified conditions, defined according to the inclusion template, a venous blood sample was taken prehospitally at the scene by the EMS.
Analysis: Significance tests and regression analyzes with 95% CI were used. The diagnostic accuracy of Q-CRP, lactate, suPAR and combinations thereof were compared with optimal boundary values.
|Study Type :||Observational|
|Actual Enrollment :||110 participants|
|Official Title:||When Triage is Insufficient - the Benefit of Bedside CRP Within Ambulance Care|
|Actual Study Start Date :||January 1, 2016|
|Actual Primary Completion Date :||September 30, 2018|
|Actual Study Completion Date :||September 30, 2018|
- Number of patients with high suPAR level [ Time Frame: 24 hours ]A high suPAR level, e.g. above 6 ng/ml
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04097210
|Study Director:||Maaret Castrén, Professor||Helsinki University Central Hospital|
|Principal Investigator:||Johanna Kaartinen, PhD||Helsinki University Central Hospital|